未登录

Y

Yong-Jia Hao

Guizhou University of Traditional Chinese Medicine

H指数:11

被引数:431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics

非靶向代谢组学揭示的黑升麻苷对肝纤维化大鼠模型的多靶点调节作用

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-01-140

OA

Construction of Difluorinated Cycloheptadienones via Substrate-Controlled Regioselective Conjugate Addition of Difluoroenoxysilanes to Tropones and Their Anticancer Activity

ADVANCED SYNTHESIS & CATALYSIS

IF4

2024-08-050

PRE

Site-Selective C-O Bond Editing of Unprotected Saccharides

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2023-12-2020

PRE

Enantioselective Synthesis of Bispiro[indanedione-oxindole-cyclopropane]s through Organocatalytic [2+1] Cycloaddition

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2022-08-1212

PRE

Construction of β-Quaternary α,α-Difluoroketones via Catalytic Nucleophilic Substitution of Tertiary Alcohols with Difluoroenoxysilanes

ORGANIC LETTERS

IF5

2020-10-1323

PREAI

A highly efficient In(OTf)3-catalyzed [3+3] annulation of spirocyclopropyl oxindoles with 1,4-di-thiane-2,5-diol

CHINESE CHEMICAL LETTERS

IF8.9

2020-03-0111

PREAI

Catalytic Enantioselective α-Arylation of Carbonyl Enolates and Related Compounds

羰基烯醇化物和相关化合物的催化对映选择性 α-芳基化

IF13.1

2019-12-1195

PREAI

Discovery and Biological evaluation of pyrimido[4,5-d] pyrimidine-2,4(1H, 3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-08-016

PREAI

Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-06-1531

PREAI

Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors

SCIENTIFIC REPORTS

IF3.9

2017-06-199

OAAI

Discovery and Structural Optimization of N5-Substituted 6,7-Dioxo-6,7-dihydropteridines as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2016-07-2127

PREAI